Oppenheimer Reiterates Outperform on Icosavax, Maintains $25 Price Target

Benzinga ·  10/02/2023 20:31

Oppenheimer analyst Hartaj Singh reiterates Icosavax (NASDAQ:ICVX) with a Outperform and maintains $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment